Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janus P Ong

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
The American Journal of Gastroenterology|September 14, 2006
ParacentesisJanus P Ong
Clinics in Liver Disease|October 7, 2005
Approach to the diagnosis and treatment of nonalcoholic fatty liver diseaseJanus P Ong, Zobair M Younossi
Annals of Hepatology|October 6, 2023
Balancing perspectives: Schistosomiasis in the liver disease landscape of the PhilippinesEric David Ornos, Janus P Ong
Gastroenterology|July 10, 2002
Is hepatocellular carcinoma part of the natural history of nonalcoholic steatohepatitis?Janus P Ong, Zobair M Younossi
Clinics in Liver Disease|June 5, 2007
Epidemiology and natural history of NAFLD and NASHJanus P Ong, Zobair M Younossi
The American Journal of Gastroenterology|September 23, 2003
Nonalcoholic fatty liver disease (NAFLD)--two decades later: are we smarter about its natural history?Janus P Ong, Zobair M Younossi
Cleveland Clinic Journal of Medicine|October 8, 2004
Managing the hematologic side effects of antiviral therapy for chronic hepatitis C: anemia, neutropenia, and thrombocytopeniaJanus P Ong, Zobair M Younossi
Cleveland Clinic Journal of Medicine|September 29, 2004
Nonalcoholic fatty liver disease and the epidemic of obesityRochelle Collantes, Janus P Ong, Zobair M Younossi
Journal of Hepatology|August 7, 2008
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver diseaseJanus P Ong, Angela Pitts, Zobair M Younossi
Hepatology (Baltimore, Md.)|August 9, 2003
Challenges of designing hepatic encephalopathy treatment trialsMadhusudhan R Sanaka, Janus P Ong, Kevin D Mullen
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
The American Journal of Gastroenterology|September 14, 2006
ParacentesisJanus P Ong
Clinics in Liver Disease|October 7, 2005
Approach to the diagnosis and treatment of nonalcoholic fatty liver diseaseJanus P Ong, Zobair M Younossi
Annals of Hepatology|October 6, 2023
Balancing perspectives: Schistosomiasis in the liver disease landscape of the PhilippinesEric David Ornos, Janus P Ong
Gastroenterology|July 10, 2002
Is hepatocellular carcinoma part of the natural history of nonalcoholic steatohepatitis?Janus P Ong, Zobair M Younossi
Clinics in Liver Disease|June 5, 2007
Epidemiology and natural history of NAFLD and NASHJanus P Ong, Zobair M Younossi
The American Journal of Gastroenterology|September 23, 2003
Nonalcoholic fatty liver disease (NAFLD)--two decades later: are we smarter about its natural history?Janus P Ong, Zobair M Younossi
Cleveland Clinic Journal of Medicine|October 8, 2004
Managing the hematologic side effects of antiviral therapy for chronic hepatitis C: anemia, neutropenia, and thrombocytopeniaJanus P Ong, Zobair M Younossi
Cleveland Clinic Journal of Medicine|September 29, 2004
Nonalcoholic fatty liver disease and the epidemic of obesityRochelle Collantes, Janus P Ong, Zobair M Younossi
Journal of Hepatology|August 7, 2008
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver diseaseJanus P Ong, Angela Pitts, Zobair M Younossi
Hepatology (Baltimore, Md.)|August 9, 2003
Challenges of designing hepatic encephalopathy treatment trialsMadhusudhan R Sanaka, Janus P Ong, Kevin D Mullen
Pageof 6